Sale!

Cancer Comprehensive Panel NGS Genetic Test

Original price was: 6,000 د.إ.Current price is: 4,400 د.إ.

-27%

The Cancer Comprehensive Panel NGS (Next-Generation Sequencing) Genetic Test, available at DNA Labs UAE, is a cutting-edge diagnostic tool designed to provide a detailed analysis of an individual’s genetic predisposition to various types of cancer. Priced at 4400 AED, this test utilizes the latest NGS technology to examine multiple genes simultaneously, allowing for the identification of mutations that could increase the risk of developing cancer.

By analyzing a wide array of genes associated with hereditary cancers, the test offers a comprehensive overview of the genetic factors that may contribute to cancer risk. This information is crucial for individuals with a family history of cancer, as it can guide personalized prevention strategies, early detection methods, and tailor treatment plans to improve outcomes.

The test is conducted at DNA Labs UAE, a facility renowned for its state-of-the-art technology and expertise in genetic testing. The process involves a simple blood draw or saliva sample from which DNA is extracted and analyzed. The results provide valuable insights into the patient’s genetic makeup, empowering them with the knowledge to take proactive steps in managing their health in collaboration with healthcare professionals.

In summary, the Cancer Comprehensive Panel NGS Genetic Test at DNA Labs UAE is a vital tool in the fight against cancer, offering individuals a deeper understanding of their genetic risk factors and facilitating informed decisions regarding their health and well-being.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Cancer Comprehensive Panel NGS Genetic Test – AED 4400.0

The Cancer Comprehensive Panel NGS Genetic DNA Test offered by DNA Labs UAE is a diagnostic test that analyzes a patient’s DNA to identify genetic mutations associated with cancer. This test is performed using next-generation sequencing (NGS) technology to detect changes in a large number of genes that may be involved in the development and progression of cancer.

Test Details

The Cancer Comprehensive Panel NGS Genetic DNA Test is typically conducted on a tumor biopsy sample or a blood sample from a patient with cancer. It can detect various genetic alterations, including single nucleotide variants (SNVs), insertions and deletions (indels), copy number variations (CNVs), and gene fusions.

The results of this test provide valuable information to oncologists and other healthcare providers, enabling them to determine the most suitable course of treatment for the patient. Additionally, the test helps identify patients who may be eligible for targeted therapies or clinical trials based on their specific genetic profile.

Overall, the Cancer Comprehensive Panel NGS Genetic DNA Test is a powerful tool for personalized medicine in the field of oncology. It allows healthcare providers to tailor treatment plans to individual patients based on their unique genetic makeup.

Test Components and Price

The Cancer Comprehensive Panel NGS Genetic DNA Test costs AED 4400.0. The test requires a blood sample or extracted DNA. Alternatively, a single drop of blood can be collected on an FTA card. The report is typically delivered within 3 to 4 weeks using NGS technology.

Pre-Test Information

Prior to undergoing the Cancer Comprehensive Panel NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session is conducted to draw a pedigree chart of family members affected with specific genes associated with cancer. Some of the genes included in the panel are ABRAXAS1, ACVRL1, AKT1, APC, ATM, AXIN2, BAP1, BARD1, BLM, BMPR1A, BRCA1, BRCA2, BRIP1, BUB1B, CASR, CDC73, CDH1, CDK4, CDKN1B, CDKN1C, CDKN2A, CEBPA, CHEK2, CTNNA1, DDX41, DICER1, DIS3L2, EGFR, EPCAM, ETV6, EXT1, EXT2, FANCC, FH, FLCN, GALNT12, GATA2, GPC3, GREM1, HNF1A, HNF1B, HOXB13, HRAS, KIF1B, KIT, MAX, MC1R, MEN1, MET, MITF, MLH1, MLH3, MRE11, MSH2, MSH3, MSH6, MUTYH, NBN, NF1, NF2, NTHL1, PALB2, PDGFRA, PHOX2B, PIK3CA, PMS1, PMS2, POLD1, POLE, POT1, PRKAR1A, PRSS1, PTCH1, PTCH2, PTEN, RAD50, RAD51C, RAD51D, RB1, RECQL, REST, RET, RNF43, RPS20, RUNX1, SAMD9L, SDHA, SDHAF2, SDHB, SDHC, SDHD, SMAD4, SMARCA2, SMARCA4, SMARCB1, SMARCE1, STK11, SUFU, TERT, TGFBR2, TMEM127, TP53, TRIP13, TSC1, TSC2, VHL, WRN, WT1, XRCC2, and XRCC3.

Conclusion

The Cancer Comprehensive Panel NGS Genetic DNA Test provided by DNA Labs UAE is an essential tool for diagnosing and treating cancer. By analyzing a patient’s DNA, this test helps identify genetic mutations associated with cancer and provides valuable information for personalized treatment plans. The test’s ability to detect a wide range of genetic alterations makes it a powerful tool in the field of oncology, enabling healthcare providers to offer targeted therapies and identify potential candidates for clinical trials.

 

Test NameCancer comprehensive panel NGS Genetic DNA Test
Components 
Price4400.0 AED
Sample ConditionBlood or Extracted DNA or One drop Blood on FTA Card
Report Delivery3 to 4 Weeks
MethodNGS Technology
Test typeCancer
DoctorOncologist
Test Department:Genetics
Pre Test InformationClinical History of Patient who is going for Cancer comprehensive panel NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ABRAXAS1, ACVRL1, AKT1, APC, ATM, AXIN2, BAP1, BARD1, BLM, BMPR1A, BRCA1, BRCA2, BRIP1, BUB1B, CASR, CDC73, CDH1, CDK4, CDKN1B, CDKN1C, CDKN2A, CEBPA, CHEK2, CTNNA1, DDX41, DICER1, DIS3L2, EGFR, EPCAM, ETV6, EXT1, EXT2, FANCC, FH, FLCN, GALNT12, GATA2, GPC3, GREM1, HNF1A, HNF1B, HOXB13, HRAS, KIF1B, KIT, MAX, MC1R, MEN1, MET, MITF, MLH1, MLH3, MRE11, MSH2, MSH3, MSH6, MUTYH, NBN, NF1, NF2, NTHL1, PALB2, PDGFRA, PHOX2B, PIK3CA, PMS1, PMS2, POLD1, POLE, POT1, PRKAR1A, PRSS1, PTCH1, PTCH2, PTEN, RAD50, RAD51C, RAD51D, RB1, RECQL, REST, RET, RNF43, RPS20, RUNX1, SAMD9L, SDHA, SDHAF2, SDHB, SDHC, SDHD, SMAD4, SMARCA2, SMARCA4, SMARCB1, SMARCE1, STK11, SUFU, TERT, TGFBR2, TMEM127, TP53, TRIP13, TSC1, TSC2, VHL, WRN, WT1, XRCC2, XRCC3
Test Details

The Cancer Comprehensive Panel NGS Genetic DNA Test is a diagnostic test that analyzes a patient’s DNA to identify genetic mutations associated with cancer. This test uses next-generation sequencing (NGS) technology to detect changes in a large number of genes that may be involved in the development and progression of cancer.

The test is typically performed on a tumor biopsy sample or a blood sample from a patient with cancer. It can detect a wide range of genetic alterations, including single nucleotide variants (SNVs), insertions and deletions (indels), copy number variations (CNVs), and gene fusions.

The results of the Cancer Comprehensive Panel NGS Genetic DNA Test can provide valuable information to oncologists and other healthcare providers, helping them to determine the best course of treatment for the patient. The test can also help identify patients who may be eligible for targeted therapies or clinical trials based on their specific genetic profile.

Overall, the Cancer Comprehensive Panel NGS Genetic DNA Test is a powerful tool for personalized medicine in the field of oncology, allowing healthcare providers to tailor treatment plans to individual patients based on their unique genetic makeup.